Host inflammatory response and clinical parameters around implants in a rat model using systemic alendronate and zoledronate acid drug administrations.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
15 03 2022
15 03 2022
Historique:
received:
08
07
2021
accepted:
22
02
2022
entrez:
16
3
2022
pubmed:
17
3
2022
medline:
6
5
2022
Statut:
epublish
Résumé
Implant outcomes in comparison to a natural tooth in a rat model using systemic alendronate and zoledronate acid drug administrations were assessed. Fifty-four Sprague-Dawley rats were randomly allocated into two experimental groups (drug application of zoledronic acid; 0.04 mg/kg intravenously once a week and alendronic acid; 0.2 mg/kg subcutaneously five times a week) and one control group with 18 animals in each group. Drug delivery was conducted for a period of 4 months. After 4 weeks either a zirconia or a titanium implant was immediately inserted in the socket of the first molar of the upper jaw. In vivo investigations included host inflammatory parameters and the implant survival and success rates for up to 3 months. Material incompatibilities against titanium and zirconia nanoparticles were evaluated in vitro after stimulation of rat spleen cells. In vivo, IL-6 release around titanium implants demonstrated significantly higher values in the control group (p = 0.02) when compared to the zoledronic acid group. Around the natural tooth without drug administration, the control group showed higher IL-6 values compared with the alendronic acid group (p = 0.01). In vitro, only lipopolysaccharide and not the implant's nanoparticles stimulated significant IL-6 and TNFα production. In terms of the primary aim of in vivo and in vitro IL-6 and TNFα measurements, no implant material was superior to the other. No significant in vitro stimulation of rat spleen cells was detected with respect to titanium oxide and zirconium oxide nanoparticles.
Identifiants
pubmed: 35292688
doi: 10.1038/s41598-022-08308-8
pii: 10.1038/s41598-022-08308-8
pmc: PMC8924183
doi:
Substances chimiques
Dental Implants
0
Interleukin-6
0
Tumor Necrosis Factor-alpha
0
Zoledronic Acid
6XC1PAD3KF
Zirconium
C6V6S92N3C
Titanium
D1JT611TNE
Alendronate
X1J18R4W8P
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4431Informations de copyright
© 2022. The Author(s).
Références
Clin Oral Investig. 2010 Feb;14(1):35-41
pubmed: 19294435
Cytokine. 2012 Aug;59(2):313-6
pubmed: 22592038
J Oral Maxillofac Surg. 2014 Oct;72(10):1937.e1-8
pubmed: 25234534
J Biol Regul Homeost Agents. 2015 Jul-Sep;29(3 Suppl 1):111-6
pubmed: 26511189
Int J Oral Maxillofac Implants. 2013 May-Jun;28(3):883-90
pubmed: 23748323
Clin Oral Investig. 2012 Feb;16(1):87-93
pubmed: 21225298
Medicine (Baltimore). 2016 Aug;95(35):e4425
pubmed: 27583850
Int J Oral Maxillofac Implants. 2012 Sep-Oct;27(5):1216-22
pubmed: 23057037
Injury. 2015;46(6):990-5
pubmed: 25744169
J Bone Joint Surg Am. 1989 Oct;71(9):1337-42
pubmed: 2793886
Breast Cancer Res Treat. 2010 Jul;122(1):181-8
pubmed: 20361252
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4578-83
pubmed: 15755807
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
J Periodontol. 1967 Nov-Dec;38(6):Suppl:610-6
pubmed: 5237684
Clin Oral Implants Res. 2018 Oct;29 Suppl 16:135-153
pubmed: 30328200
Oral Microbiol Immunol. 1987 Dec;2(4):145-51
pubmed: 3507627
Mayo Clin Proc. 2008 Sep;83(9):1032-45
pubmed: 18775204
Onkologie. 2012;35(11):658-64
pubmed: 23147542
J Clin Oncol. 2009 Nov 10;27(32):5356-62
pubmed: 19805682
Iran J Allergy Asthma Immunol. 2013 Mar;12(1):75-80
pubmed: 23454782
Clin Oral Investig. 2013 Jan;17(1):167-75
pubmed: 22415216
Nanomedicine. 2011 Dec;7(6):975-82
pubmed: 21645642
J Prosthodont Res. 2018 Oct;62(4):397-406
pubmed: 29983377
Br J Oral Maxillofac Surg. 2013 Dec;51(8):874-9
pubmed: 23866309
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S287-S296
pubmed: 30648446
Clin Oral Implants Res. 2016 Feb;27(2):211-7
pubmed: 25682848
Implant Dent. 2007 Mar;16(1):80-8
pubmed: 17356374
Implant Dent. 2015 Jun;24(3):328-32
pubmed: 25764480
J Mech Behav Biomed Mater. 2021 Jul;119:104515
pubmed: 33932754
Clin Oral Implants Res. 2020 Oct;31(10):889-916
pubmed: 32654230
J Clin Oncol. 2011 Mar 20;29(9):1125-32
pubmed: 21343556
J Craniomaxillofac Surg. 2017 Sep;45(9):1493-1502
pubmed: 28687467
Int J Oral Maxillofac Surg. 2019 Apr;48(4):554-559
pubmed: 30409453
Int J Implant Dent. 2016 Dec;2(1):9
pubmed: 27747701
J Dent Res. 2013 Mar;92(3):279-83
pubmed: 23264610
Dent Mater. 2020 Mar;36(3):402-412
pubmed: 31992485
J Oral Maxillofac Surg. 2010 Feb;68(2):337-43
pubmed: 20116705
Int J Oral Maxillofac Surg. 2012 Nov;41(11):1404-9
pubmed: 22704590
Oral Surg Oral Med Oral Pathol Oral Radiol. 2012 Sep;114(3):318-24
pubmed: 22862971
Biomaterials. 2005 Apr;26(11):1271-86
pubmed: 15475057
Tissue Eng. 1996 Summer;2(2):127-40
pubmed: 19877935
Clin Oral Investig. 2011 Feb;15(1):105-11
pubmed: 20024592
SSO Schweiz Monatsschr Zahnheilkd. 1975 Sep;85(9):905-19
pubmed: 1059253
Int J Oral Maxillofac Surg. 2019 Apr;48(4):560-565
pubmed: 30392706
Materials (Basel). 2021 Nov 11;14(22):
pubmed: 34832201
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):61-70
pubmed: 19371816
Clin Oral Implants Res. 2014 May;25(5):632-40
pubmed: 23278625
Clin Implant Dent Relat Res. 2014 Oct;16(5):751-61
pubmed: 23445465
J Oral Maxillofac Surg. 2008 May;66(5):1022-4
pubmed: 18423296
Compend Contin Educ Dent. 2011 Jul-Aug;32(6):E106-9
pubmed: 23738968
Arch Oral Biol. 2011 Aug;56(8):823-8
pubmed: 21306703
Gerontology. 2015;61(6):534-42
pubmed: 25720990